NeuroPace, Inc. (NPCE) NASDAQ

10.60

+0.17(+1.63%)

Updated at March 14 01:38PM

Currency In USD

NeuroPace, Inc.

Address

455 North Bernardo Avenue

Mountain View, CA 94043

United States of America

Phone

650 237 2700

Sector

Healthcare

Industry

Medical - Devices

Employees

184

First IPO Date

April 22, 2021

Key Executives

NameTitlePayYear Born
Mr. Joel D. BeckerChief Executive Officer, President & Director761,9961968
Ms. Rebecca L. KuhnChief Financial Officer and Vice President of Finance & Administration614,9111961
Dr. Martha J. Morrell M.D.Chief Medical Officer728,6761957
Ms. Amy TreadwellVice President of Human Resources0N/A
Ms. Katie KellerVice President of Marketing0N/A
Ms. Kelley NicholasVice President of Sales0N/A
Mr. Dylan St. JohnChief of Operations & Development0N/A
Ms. Leah AkinGeneral Counsel & Corporate Secretary0N/A

Description

NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.